Find a Physician

Profile http://www.stanfordhospital.org/profiles/Robert_Shafer/
Email this profile
Portrait View Larger

Robert W. Shafer

Academic Appointments

  • Professor (Research) of Medicine (Infectious Diseases and Geographic Medicine) and, by courtesy, of Pathology

Key Documents

Contact Information

  • Clinical Offices
    Division of Infectious Diseases Dept of Medicine 300 Pasteur Dr Grant Bldg Room S-101 Stanford, CA 94305
    Tel Work (650) 725-2946 Fax (650) 725-2088
  • Academic Offices
    Personal Information
    Email Tel (650) 725-2946
    Not for medical emergencies or patient use

Professional Overview

Clinical Focus

  • Infectious Disease

Academic Appointments

Professional Education

Residency: Lenox Hill Hospital NY (1986)
Medical Education: New York University - School Of Medicine NY (1983)
Fellowship: Stanford University School of Medicine CA (1993)
Fellowship: SUNY at Brooklyn School Of Medicine NY (1988)
Board Certification: Infectious Disease, American Board of Internal Medicine (1988)
Board Certification: Internal Medicine, American Board of Internal Medicine (1986)
View All 7

Courses

2013-14

Prior Year Coursescourses of Robert Shafer

Postdoctoral Advisees

Dana Clutter

Graduate and Fellowship Program Affiliations

Scientific Focus

Current Research and Scholarly Interests

My group’s research is on the mechanisms and consequences of virus evolution with a focus on HIV therapy and drug resistance. We maintain a public HIV drug resistance database (http://hivdb.stanford.edu) as a resource for HIV drug resistance surveillance, interpreting HIV drug resistance tests, and HIV drug development. These three disciplines – epidemiology, clinical management, and basic science – reflect the interdisciplinary nature of antiviral drug resistance research and represent the range of our group’s activities.

HIV drug resistance, once the main challenge to the very concept that antiretroviral therapy would be possible, has been countered in a striking success of modern medicine. However, HIV drug resistance persists as the main threat to the long-term effectiveness of antiretroviral therapy in the under-resourced parts of the world with the highest numbers of HIV-infected people. The paramount goal of our group's work is to inform HIV treatment and prevention policies by identifying the most important factors responsible for the emergence and spread of drug resistance.

Additional interests of our group include sequence analyses that provide insight into viral pathogenesis, open source informatics approaches that facilitate the use of genomic data in clinical practice, and new sequencing technologies.

Publications

Publication tag cloud

Publication Topics

View All 196

Stanford Medicine Resources:

Footer Links: